Publicaciones en la fuente CURRENT PHARMACEUTICAL DESIGN

Tipo Año Título Fuente
Nota2022Opium, street opium, and cancer riskCURRENT PHARMACEUTICAL DESIGN
Artículo2021Anticholinergic exposure in elderly complex chronic patients: a cross-sectional studyCURRENT PHARMACEUTICAL DESIGN
Artículo2018Association Between Drug Burden Index and Functional and Cognitive Function in Patients with MultimorbidityCURRENT PHARMACEUTICAL DESIGN
Editorial2018Current advances in pharmacotherapy and drug design against inflammatory-related pathologiesCURRENT PHARMACEUTICAL DESIGN
Revisión2018Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative DiseasesCURRENT PHARMACEUTICAL DESIGN
Revisión2018Role of Melatonin in the Inflammatory Process and its Therapeutic PotentialCURRENT PHARMACEUTICAL DESIGN
Revisión2018Signaling Pathways in Inflammation and Anti-inflammatory TherapiesCURRENT PHARMACEUTICAL DESIGN
Revisión2017Application of Kinase Inhibitors for Anti-aging InterventionCURRENT PHARMACEUTICAL DESIGN
Artículo2016Intracellular Drug Delivery: Mechanisms for Cell EntryCURRENT PHARMACEUTICAL DESIGN
Revisión2016Statins in Stroke Prevention: Present and FutureCURRENT PHARMACEUTICAL DESIGN
Artículo2015Nano-sized platforms for vaginal drug deliveryCURRENT PHARMACEUTICAL DESIGN
Artículo2015Polysaccharide Colloids as Smart Vehicles in Cancer TherapyCURRENT PHARMACEUTICAL DESIGN
Artículo2014CD95 Signaling in Cancer TreatmentCURRENT PHARMACEUTICAL DESIGN
Artículo2014Melatonin and Glucose Metabolism: Clinical RelevanceCURRENT PHARMACEUTICAL DESIGN
Revisión2014Melatonin, autophagy and intestinal bowel diseaseCURRENT PHARMACEUTICAL DESIGN
Artículo2014Restoring cortical connectivity directionality and synchronization is essential to treating disorder of consciousnessCURRENT PHARMACEUTICAL DESIGN
Editorial2014Targeting Cell Death and Proliferation Receptors in CancerCURRENT PHARMACEUTICAL DESIGN
Artículo2014The Long and Winding Road to Cancer Treatment: The Trail SystemCURRENT PHARMACEUTICAL DESIGN
Revisión2012Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon CancerCURRENT PHARMACEUTICAL DESIGN
Revisión2012Gene-environment interactions underlying the effect of cannabis in first episode psychosisCURRENT PHARMACEUTICAL DESIGN
Editorial2012Inflammation and Cancer: New Targets and Novel Therapeutic ApproachCURRENT PHARMACEUTICAL DESIGN
Revisión2012Intracellular Proton Pumps as Targets in Chemotherapy: V-ATPases and CancerCURRENT PHARMACEUTICAL DESIGN
Artículo2012Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of ParadoxCURRENT PHARMACEUTICAL DESIGN
Revisión2012Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.CURRENT PHARMACEUTICAL DESIGN
Revisión2012Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal CancerCURRENT PHARMACEUTICAL DESIGN
Editorial2011An Up-Date of Olive Oil and Bioactive Constituents in Health: Molecular Mechanisms and Clinical ImplicationsCURRENT PHARMACEUTICAL DESIGN
Revisión2011Mitochondrial Drug Targets in Cell Death and CancerCURRENT PHARMACEUTICAL DESIGN
Revisión2011Oleic acid in olive oil: from a metabolic framework toward a clinical perspectiveCURRENT PHARMACEUTICAL DESIGN
Revisión2008Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activitiesCURRENT PHARMACEUTICAL DESIGN
Revisión2007Poly(ADP-ribose) polymerase inhibitors: New pharmacological functions and potential clinical implicationsCURRENT PHARMACEUTICAL DESIGN
Revisión2004Importance of Aquaporins in the Physiopathology of Brain EdemaCURRENT PHARMACEUTICAL DESIGN
Revisión2004New pharmacological perspectives and therapeutic potential of PPAR-gamma agonistsCURRENT PHARMACEUTICAL DESIGN
Revisión2004Structural process and implementation programs of pharmaceutical care in different countriesCURRENT PHARMACEUTICAL DESIGN
Revisión2001Antiinflamatory agents less dangerous for gastrointestinal tractCURRENT PHARMACEUTICAL DESIGN
Revisión2001Mediterranean diet and health: Biological importance of olive oilCURRENT PHARMACEUTICAL DESIGN
Revisión2001New issues about melatonin and its effects on the digestive systemCURRENT PHARMACEUTICAL DESIGN
Revisión2001New issues about nitric oxide and its effects on the gastrointestinal tractCURRENT PHARMACEUTICAL DESIGN
Editorial2001PrefaceCURRENT PHARMACEUTICAL DESIGN